Jushi Holdings Inc. Reports Third Quarter 2026 Financial Results

Jushi’s Q3 2026 revenue rose 7% year over year to $70.5 million, while wholesale revenue increased 40% to a second consecutive quarterly record of $9.7 million. Adjusted EBITDA improved to $13.6 million from $12.8 million, and net loss narrowed to $12.5 million from $23.7 million; gross margin eased to 45.9% from 46.7% amid pricing pressure. The company ended the quarter with $30.9 million in cash, cash equivalents and restricted cash against $215.6 million of scheduled-repayment gross debt, and is preparing for Virginia adult-use sales scheduled to begin July 1, 2027.

Analysis

The quality of the quarter is weaker than the headline growth suggests: unit growth is outpacing retail revenue, consistent with price/mix pressure, while gross margin and Adjusted EBITDA margin slipped. The improvement in GAAP loss is not a clean operating inflection; the prior-year derivative loss makes the comparison unusually favorable, and interest expense still exceeds operating income by a wide margin. Wholesale expansion may improve utilization and distribution, but it is not yet translating into margin expansion.

The binding constraint is financing, not demand alone. Cash is modest relative to scheduled debt, near-term maturities have risen, and Virginia capacity investment must be funded before the adult-use start date. That creates a potentially adverse sequence: spend ahead of regulatory revenue, then refinance or issue equity if timing or liquidity disappoints. The fully diluted share count materially exceeds basic shares, so financing could carry meaningful dilution risk. Separately, the large unrecognized tax-benefit balance is a contingent liquidity and valuation risk; verify status and timing rather than treating it as immediately payable.

Near term, expect the call and any financing details to matter more than the revenue beat. Over 1–3 months, watch cash conversion, debt maturities/refinancing terms, and Virginia project commitments. Over 6–18 months, adult-use timing could create upside, but competition and price compression may absorb volume gains. The contrarian point: the market may over-credit Virginia optionality while underweighting the cost and funding bridge required to reach it. No high-conviction directional trade without valuation, debt terms, and liquidity runway data.

Key Decisions for Investors

• Do not chase the earnings headline; keep exposure neutral pending the conference call and verify the debt maturity schedule, covenant headroom, financing alternatives, and Virginia capex commitments.
• If already long, size the position against refinancing and dilution risk. Reassess on evidence of sustained operating cash generation and stable/improving gross margin—not Adjusted EBITDA growth alone.
• Treat Virginia adult-use as a catalyst watch, not a base-case valuation premium: monitor regulatory milestones and project funding, and reduce the thesis if launch timing slips or capital is raised on materially dilutive terms.
• For a short-term catalyst checklist, track average selling price versus units, wholesale gross economics, quarterly operating cash flow, and tax-benefit developments; deterioration in these measures would falsify the operating-improvement case.